MDMAT
MDMAT (6,7-methylenedioxy-N-methyl-2-aminotetralin) is a selective serotonin releasing agent (SSRA) and entactogen drug. It is the N-methylated derivative of MDAT, similarly to the relationship of MDMA to MDA.[2][3] It has been theorized to have less long-term neurotoxicity and less hallucinogenic effects than other MDxx derivatives,[4] but no formal scientific research has been conducted specifically on MDMAT. There is a lack of research on MDMAT in general, with much of the research and citation in literature being in reference to the wider pharmalogical/chemical class as a whole. ChemistryMDMAT is a substituted methylenedioxyphenethylamine, having structural similarities to MDMA and MDA. See alsoReferences
|